Brasilia (Reuters) – Brazil health authority Anvisa said on Wednesday that trials of the COVID-19 vaccine developed by AstraZeneca and University of Oxford would continue after the death of volunteer involved in the tests.
Anvisa gave no further details on the death, citing confidentiality protocols.
Date:
Latest
For Kuwait’s new emir, Saudi ties are seen as key
Kuwait (Reuters) - Sheikh Meshal al-Ahmad al-Sabah was named...
Pope Francis deplores Israeli killings of civilians at Gaza church
Vatican City (Reuters) - Pope Francis on Sunday again...
Palestinians must find new path from Israeli rule after war, top official says
Ramallah (Reuters) - Immediately after Israel's war in Gaza...
Israel says it struck Hezbollah sites after attacks from Lebanon
Jerusalem/Beirut (Reuters) - Israel said on Sunday it had...